These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9704922)

  • 1. At the onset of transformation polyomavirus middle-T recruits shc and src to a perinuclear compartment coincident with condensation of endosomes.
    Zhu W; Eicher A; Leber B; Andrews DW
    Oncogene; 1998 Aug; 17(5):565-76. PubMed ID: 9704922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
    Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
    Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.
    Webster MA; Hutchinson JN; Rauh MJ; Muthuswamy SK; Anton M; Tortorice CG; Cardiff RD; Graham FL; Hassell JA; Muller WJ
    Mol Cell Biol; 1998 Apr; 18(4):2344-59. PubMed ID: 9528804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen.
    Campbell KS; Ogris E; Burke B; Su W; Auger KR; Druker BJ; Schaffhausen BS; Roberts TM; Pallas DC
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6344-8. PubMed ID: 8022784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of proline-rich domain in polyomavirus T antigens results in virus partially defective in transformation and tumorigenesis.
    Yi X; Freund R
    Virology; 1998 Sep; 248(2):420-31. PubMed ID: 9721249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.
    Denis D; Rouleau C; Schaffhausen BS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A.
    Mullane KP; Ratnofsky M; Culleré X; Schaffhausen B
    Mol Cell Biol; 1998 Dec; 18(12):7556-64. PubMed ID: 9819441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein.
    Rauh MJ; Blackmore V; Andrechek ER; Tortorice CG; Daly R; Lai VK; Pawson T; Cardiff RD; Siegel PM; Muller WJ
    Mol Cell Biol; 1999 Dec; 19(12):8169-79. PubMed ID: 10567542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
    Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
    J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells.
    Whalen KA; Weber GF; Benjamin TL; Schaffhausen BS
    J Virol; 2008 May; 82(10):4946-54. PubMed ID: 18337582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
    Smit L; van der Horst G; Borst J
    Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for the small GTPase Rac in polyomavirus middle-T antigen-mediated activation of the serum response element and in cell transformation.
    Urich M; Senften M; Shaw PE; Ballmer-Hofer K
    Oncogene; 1997 Mar; 14(10):1235-41. PubMed ID: 9121774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Middle T antigen activation of signal transduction pathways does not overcome p53-mediated growth arrest.
    Doherty J; Freund R
    J Virol; 1999 Sep; 73(9):7882-5. PubMed ID: 10438885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative involvement of Shc tyrosine 239/240 and tyrosine 317 on insulin induced mitogenic signaling in rat1 fibroblasts expressing insulin receptors.
    Ishihara H; Sasaoka T; Wada T; Ishiki M; Haruta T; Usui I; Iwata M; Takano A; Uno T; Ueno E; Kobayashi M
    Biochem Biophys Res Commun; 1998 Nov; 252(1):139-44. PubMed ID: 9813159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
    Jelinek MA; Hassell JA
    Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells.
    Curto M; Frankel P; Carrero A; Foster DA
    Biochem Biophys Res Commun; 1998 Feb; 243(2):555-60. PubMed ID: 9480847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells.
    Schmandt R; Liu SK; McGlade CJ
    Oncogene; 1999 Mar; 18(10):1867-79. PubMed ID: 10086341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein interactions of Src homology 2 (SH2) domain-containing inositol phosphatase (SHIP): association with Shc displaces SHIP from FcgammaRIIb in B cells.
    Tridandapani S; Pradhan M; LaDine JR; Garber S; Anderson CL; Coggeshall KM
    J Immunol; 1999 Feb; 162(3):1408-14. PubMed ID: 9973396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.
    Liu SK; McGlade CJ
    Oncogene; 1998 Dec; 17(24):3073-82. PubMed ID: 9872323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
    Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
    Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.